ENTITY

Gw Pharmaceuticals (GWP LN)

Analysis

Health Care • United Kingdom

GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.

Refresh

No events found

We’ll display events we find for Gw Pharmaceuticals here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00